|
13th GAVI BOARD MEETING
Washington, DC, 6-7 July 2004
FINAL SUMMARY REPORT
>>Back to the 13th GAVI Board Meeting
6. Measles Investment Case
- The document provided as an addendum to the original measles investment case addresses the concerns raised by the Board.
- Channeling some of the $50 million through the GAVI/Vaccine Fund country support mechanism would result in a $3 million loss in matching grants from the UN Foundation. However, upholding the GAVI emphasis on bottom-up country application processes would be worth the reduced financial contribution.
DECISIONS
The Board:
6.1 Approved option B outlined in the addendum of the measles investment case, namely:
6.1.1 The Vaccine Fund will contribute $37 million to the UN Foundation for "catch-up" campaigns. This will trigger a $9.25 million matching grant from the UN Foundation. The relevant countries will access resources for catch-up campaigns through the Measles Partnership.
6.1.2 The Vaccine Fund will make available $13 million to support implementation of a routine second dose of measles vaccine in selected countries. The relevant countries will access resources for routine second measles dose through GAVI/Vaccine Fund country application mechanism.
>>Back to the 13th GAVI Board Meeting
 |